S. Richards

发表

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

G. Morgan, D. Catovsky, D. Gonzalez, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.

S. Richards, S. Brandalise, A. Sasse, 2005, The Cochrane database of systematic reviews.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, G Middleton, 1997, The Lancet.

Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.

R. Wade, S. Richards, A. Vora, 2013, British journal of clinical pharmacology.

Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocols

S. Richards, R. Ramanujachar, I. Hann, 2006, Pediatric blood & cancer.

Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.

R. Pieters, S. Richards, T. Eden, 2009, British journal of haematology.

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute Lymphoblastic leukaemia, 1980–2001

S. Richards, C. Harrison, T. Eden, 2009, Leukemia.

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997

S. Richards, O. Eden, J. Lilleyman, 2000, Leukemia.

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X

C. C. Bailey, S. Richards, S. M. Richards, 1995, The Lancet.

High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis

S. Richards, J. Rowe, A. Goldstone, 2008, Leukemia.

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.

C Warlow, B. Farrell, C. Warlow, 1991, Journal of neurology, neurosurgery, and psychiatry.

randomized prospective trial (UKALL XII/ECOG 2993) immunophenotype, cytogenetics, and outcome from the large T-cell acute lymphoblastic leukemia in adults: clinical features,

A. Ferrando, S. Richards, G. Dewald, 2013 .

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

A. Ferrando, M. Tallman, S. Richards, 2009, Blood.

Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard arm.

S. Richards, K. Wheatley, R. Hills, 2003, Leukemia research.

Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

S. Richards, L. Foroni, G. Gerrard, 2010, British journal of haematology.

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin

S. Richards, J. Lilleyman, F. Hill, 1997, British journal of haematology.

Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study.

H. R. Taylor, R. Collins, A. Brownlie, 1996, Journal of neurology, neurosurgery, and psychiatry.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

H. R. Taylor, R. Collins, A. Brownlie, 1997, The Lancet.

Systematic review and meta‐analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia

C. Pui, S. Richards, P. Gayon, 2013, Pediatric blood & cancer.

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

M. Tallman, S. Richards, L. Foroni, 2006, Blood.

Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia.

S. Richards, O. Eden, M. Shaw, 1990, Medical and pediatric oncology.

XII/ECOG E2993 of more than 1500 patients from the international ALL trial: MRC UKALL Induction therapy for adults with acute lymphoblastic leukemia: results

S. Richards, H. Prentice, R. Chopra, 2008 .

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

M. Tallman, S. Richards, H. Prentice, 2005, Blood.

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.

M. Tallman, S. Richards, L. Foroni, 2009, Blood.

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials

M. Steurer, S. Richards, 2011, Haematologica.

Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain

C. Stiller, S. Richards, C. Mitchell, 2012, British Journal of Cancer.

HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial

G. M. Taylor, R. Wade, S. Richards, 2012, Blood Cancer Journal.

Therapeutic interventions for Burkitt lymphoma in children.

S. Richards, N. Skoetz, M. Meremikwu, 2011, The Cochrane database of systematic reviews.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

R. Greil, G. Schwarzer, M. Steurer, 2006, Cancer treatment reviews.

Severe cytopenias associated with the sequential use of busulphan and interferon‐alpha in chronic myeloid leukaemia

S. Richards, P. Shepherd, N. Allan, 1994, British journal of haematology.

Recruitment of childhood leukaemia patients to clinical trials in Great Britain during 1980–2007: variation by birth weight, congenital malformation, socioeconomic status and ethnicity

M. Stevens, C. Stiller, S. Richards, 2014, Archives of Disease in Childhood.

CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.

R. Peto, S. Richards, G. Masera, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of CML using IFN-alpha: impact on quality of life.

S. Richards, J. Halsey, J. Homewood, 2003, The hematology journal : the official journal of the European Haematology Association.

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

M. Tallman, S. Richards, R. Chopra, 2006, Blood.

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

D. J. King, H. McLeod, A. Hall, 1999, British journal of haematology.

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

S. Richards, A. Vora, J. Lilleyman, 2005, British journal of haematology.

Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial

R. Peto, S. Awasthi, S. Richards, 2013, The Lancet.

A Comparison of Cox Regression and Neural Networks for Risk Stratification in Cases of Acute Lymphoblastic Leukaemia in Children

J. M. Chessells, C. C. Bailey, S. Richards, 1999, Neural computing & applications (Print).

Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.

S. Richards, J. Rowe, Vikas Gupta, 2013, Blood.

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

S. Richards, C. Harrison, A. Vora, 2007, Blood.

Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.

M. Dyer, T. Stankovic, P. Moss, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thiopurine methyltransferase genotypephenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia

R. Wade, S. Richards, A. Vora, 2013 .

Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial

D. Catovsky, R. Wade, S. Richards, 2008, British journal of haematology.

Response: chemotherapy versus allogeneic transplantation in adult patients with acute lymphoblastic leukemia in first remission--not a time for dogma.

S. Richards, J. Rowe, Vikas Gupta, 2013, Blood.

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.

S. Richards, C. Harrison, C. Schwab, 2010, The Lancet. Oncology.

Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials

E. Kimby, F. Bosch, E. Montserrat, 1999 .

Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.

H. Heimpel, R. Peto, J. Hasford, 1997, Journal of the National Cancer Institute.

Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta‐analysis of three randomized trials

H. Heimpel, J. Hasford, J. Godwin, 2000, British journal of haematology.

Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression

S. Richards, C. Harrison, A. Moorman, 2002 .

Effect of Age and Relation to Mortality on Serial Changes of Vasoactive Intestinal Peptide ir Acute Myocardial Infarction

L. Shaw, B. Chaitman, C. Warlow, 1996 .

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.

S. Richards, J. Lilleyman, G. Dolan, 1989, Archives of disease in childhood.

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

S. Richards, O. Eden, J. Lilleyman, 2000, Leukemia.

8 Interferon-α: results from randomized trials

S. Richards, 1997 .

Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups.

S. le Cessie, A. Green, J. Falkenburg, 2004, Blood.

Assessment of fl udarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

D. Catovsky, D. Oscier, E. Matutes, 2007 .

Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.

S. Richards, 2005, Cancer treatment reviews.

The UK Medical Research Council CLL trials 1 and 2.

D. Catovsky, S. Richards, J. Fooks, 1988, Nouvelle revue francaise d'hematologie.

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation.

R. Brand, M. Hallek, D. Catovsky, 2011, Blood.

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

M. Tallman, S. Richards, A. Moorman, 2012, British journal of haematology.

(ALL); an MRC UKALL12/ECOG 2993 study Outcome of 609 adults after relapse of acute lymphoblastic leukaemia

S. Richards, R. Chopra, H. Lazarus, 2012 .

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.

S. Richards, R. Hardy, J. Chessells, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of risk stratification by early bone‐marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99

R. Wade, S. Richards, A. Vora, 2009, British journal of haematology.

Relationship between HLA‐DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?

G. M. Taylor, R. Wade, S. Richards, 2009, British journal of haematology.

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial

S. Richards, A. Vora, J. Lilleyman, 2006, The Lancet.

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.

S. Richards, J. Lilleyman, O. Eden, 1994, Leukemia.

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.

S. Richards, K. Wheeler, J. Chessells, 1992, Lancet.

Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993)

M. Tallman, S. Richards, H. Prentice, 2001 .

Cochrane review: Therapeutic interventions for Burkitt's lymphoma in children

T. Lasserson, S. Richards, M. Meremikwu, 2007 .

Assessment of fl udarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

D. Catovsky, D. Oscier, E. Matutes, 2007 .

Cytogenetics of long‐term survivors of ETV6‐RUNX1 fusion positive acute lymphoblastic leukemia

S. Richards, C. Harrison, J. Swansbury, 2009, Genes, chromosomes & cancer.

ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications

S. Richards, F. Ross, C. Harrison, 2005, Genes, chromosomes & cancer.

Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.

S. Richards, J. Hancock, C. Harrison, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

S. Richards, A. Vora, N. Goulden, 2010, British journal of haematology.

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

C. Bloomfield, J. Byrd, R. Vij, 2009 .

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial

D. Catovsky, C. Dearden, S. Richards, 2011, Cancer.

CNS-Directed T herapy f or C hildhood A cute L ymphoblastic Leukemia: C hildhood A LL C ollaborative G roup O verview o f 4 3 Randomized T rials

R. Peto, S. Richards, G. Masera, 2003 .

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry

D. Catovsky, E. Matutes, S. Richards, 2012, Leukemia.

Temporal changes in incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council Trials, 1985–2001

R. Wade, S. Richards, A. Vora, 2009, Leukemia.

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial

D. Catovsky, R. Wade, S. Richards, 2012, Leukemia & lymphoma.

The thiopurine methyltransferase genetic polymorphism is associated with thioguanine‐related veno‐occlusive disease of the liver in children with acute lymphoblastic leukemia

S. Richards, A. Vora, J. Lilleyman, 2006, Clinical pharmacology and therapeutics.

Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial.

Xiaochun Li, M. Tallman, S. Richards, 2008 .

Late Relapsing Childhood Lymphoblastic Leukemia

S. Richards, G. Wilson, A. Vora, 1998 .

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

G. Morgan, D. Catovsky, D. Gonzalez, 2008 .

Involvement of the MLL gene in T-lineage acute lymphoblastic leukemia.

S. Richards, C. Harrison, A. Moorman, 2002, Blood.

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA

S. Richards, I. J. Durrant, H. Grant Prentice, 1997, British journal of haematology.

Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.

L. M. Anderson, S. Richards, J. Lilleyman, 1994, Journal of clinical pathology.

Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial.

A. Pettitt, D. Catovsky, E. Matutes, 2004 .

Early Results from LRF CLL4: A UK Multicenter Randomized Trial.

D. Catovsky, S. Richards, P. Hillmen, 2005 .

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

James Allan, E. Papaemmanuil, J. Vijayakrishnan, 2010, Nature Genetics.

Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

S. Richards, A. Vora, N. Goulden, 2011, Blood.

Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.

J Wahrendorf, M. Pike, N. Day, 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Supplement.

A second course of treatment for childhood acute lymphoblastic leukaemia: long‐term follow‐up is needed to assess results

S. Richards, A. Leiper, J. Chessells, 1994, British journal of haematology.

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

J. Peto, S. Richards, J. Lilleyman, 1991, British journal of haematology.

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI

S. Richards, F. Hill, G. Harrison, 2002, British journal of haematology.

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

S. Richards, N. C. Allan, P. C. A. Shepherd, 1995, The Lancet.

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

D. Catovsky, R. Wade, D. Oscier, 2010, Haematologica.

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

T Hamblin, A. Pettitt, D. Catovsky, 2007, The Lancet.

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival

D. Catovsky, S. Richards, J. Fooks, 1989, British journal of haematology.

WT1 mutations in T-ALL.

A. Ferrando, R. Pieters, T. Palomero, 2009, Blood.

WT 1 mutations in TALL

A. Ferrando, R. Pieters, T. Palomero, 2009 .

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

A. Ferrando, M. Sulis, M. Tallman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive Biomarkers and Personalized Medicine Functional Analysis of the ATM-p 53-p 21 Pathway in the LRF CLL 4 Trial : Blockade at the Level of p 21 Is Associated with Short Response Duration

A. Pettitt, D. Catovsky, D. Gonzalez, 2012 .

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

C. Pui, A. Baruchel, L. Silverman, 2012, The New England journal of medicine.

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

S. Richards, F. Hill, E. Morris, 2003, British Journal of Haematology.

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

S. Richards, F. Hill, G. Harrison, 2001, Archives of disease in childhood.

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

S. Richards, A. Vora, O. Eden, 2001, British journal of haematology.

Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)

S. Richards, D. Hargrave, O. Eden, 2001, British journal of haematology.

Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.

S. Richards, F. Hill, K. Wheeler, 2000, Blood.

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

S. Richards, S. Lawson, O. Eden, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A Comparison of Cox Regression and Neural Networks for Risk Stratification in Cases of Acute Lymphoblastic Leukaemia in Children

Steve W. Smye, C. C. Bailey, D. J. Groves, 1999, Neural Computing & Applications.

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience

S. Richards, K. Wheeler, J. Chessells, 1998, British journal of haematology.

Late relapsing childhood lymphoblastic leukemia.

S. Richards, G. Wilson, A. Vora, 1998, Blood.

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X

S. Richards, J. Chessells, C. Bailey, 1997, British journal of haematology.

S. Richards, K. Wheeler, J. Chessells, 1996, Archives of disease in childhood.

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALLX

S. Richards, K. Wheeler, J. Chessells, 1992, The Lancet.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

C. Pui, N. Heerema, A. Baruchel, 2003, Leukemia.

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)

S. Richards, C. Harrison, O. Eden, 2004, British journal of haematology.

Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

S. Richards, A. Vora, J. Rowe, 2007, Pediatric blood & cancer.

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.

M. Baccarani, H. Kluin-Nelemans, G. Rosti, 2001, Blood.

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

R. Wade, S. Richards, J. Hancock, 2013, The Lancet. Oncology.

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia

S. Richards, I. J. Durrant, 1993, British journal of haematology.

Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.

L. Jannoun, B. Kendall, S. Richards, 1990, Archives of disease in childhood.

The Medical Research Council trials in adult acute lymphocytic leukemia.

S. Richards, A. Goldstone, H. G. Prentice, 2000, Hematology/oncology clinics of North America.

Long survival in childhood lymphoblastic leukaemia.

S. Richards, J. Chessells, R. Hardisty, 1987, British Journal of Cancer.

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

S. Richards, A. Vora, A. Moorman, 2004, British journal of haematology.

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity

D. Neuberg, J. Bennett, S. Richards, 2001, American journal of hematology.

Children under two years treated according to the Medical Research Council UKALL VIII study and trial 1980-1984 (on behalf of the Medical Research Council Working Party on Leukaemia in Childhood).

S. Richards, O. Eden, M. Shaw, 1992, The British journal of cancer. Supplement.

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.

Mike Clarke, K Wheatley, A Riccardi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long‐term follow‐up

S. Richards, S. Lawler, J. Chessells, 1989, British journal of haematology.

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.

S. Richards, C. Harrison, C. Schwab, 2011, Blood.

identification of genetic variants influencing prognosis Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the

S. Richard, D. Catovsky, R. Wade, 2013 .

Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.

R. Houlston, D. Catovsky, R. Wade, 2008, Blood.

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.

P. Mcgale, S. Richards, J. Boultwood, 2000, Blood.

French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.

S. Richards, O. Eden, R. Stevens, 1986, Journal of clinical pathology.

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.

D. Catovsky, R. Wade, C. Dearden, 2008, Blood.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Rajesh Chopra, M. Tallman, S. Richards, 2007, Blood.

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.

S. Richards, C. Harrison, A. Moorman, 2003, Blood.

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

A. Cherry, M. Tallman, S. Richards, 2005, Blood.

Colony‐stimulating factors for prevention of myelosuppressive therapy‐induced febrile neutropenia in children with acute lymphoblastic leukaemia

S. Richards, S. Brandalise, A. Sasse, 2005 .

A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia

R. Peto, F. Mandelli, R. Gray, 1998, British journal of haematology.

S. Richards, A. Vora, O. Eden, 2003 .

MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.

S. Richards, J. Chessells, C. Bailey, 1992, Leukemia.

Remission death in acute lymphoblastic leukaemia: a changing pattern.

S. Richards, J. Chessells, A. Atra, 1993, Archives of disease in childhood.

Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia

S. Richards, G. Escherich, A. Vora, 2011, Leukemia.

leukaemia : a changing pattern . Remission death in acute lymphoblastic

S. Richards, J. Chessells, 2004 .

Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration

A. Pettitt, D. Catovsky, D. Gonzalez, 2012, Clinical Cancer Research.

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI

F. Vargha-Khadem, S. Richards, C. Halsey, 2011, Journal of hematology & oncology.

and cyclophosphamide on the incidence of hemolytic anemia fludarabine lymphocytic leukemia - a beneficial effect of the combination of The prognostic significance of a positive direct antiglobulin test in chronic

R. Wade, C. Dearden, S. Richards, 2013 .

Chlorambucil--still not bad: a reappraisal.

D. Catovsky, S. Richards, M. Else, 2011, Clinical lymphoma, myeloma & leukemia.

Purine antagonists for chronic lymphocytic leukaemia.

R. Greil, G. Schwarzer, M. Steurer, 2006, The Cochrane database of systematic reviews.

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell‐origin of ALL subgroups – a UKALLXII study

S. Richards, L. Foroni, A. Moorman, 2010, British journal of haematology.

Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial

R. Houlston, D. Rossi, G. Gaidano, 2011 .

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

D. Catovsky, S. Richards, T. Hamblin, 1991, Leukemia & lymphoma.

No association of HLA‐A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial

R. Wade, S. Richards, T. Eden, 2011, British journal of haematology.

Blast cell vacuoles in childhood lymphoblastic leukaemia

S. Richards, O. Eden, R. Stevens, 1988, British journal of haematology.

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

S. Richards, N C Allan, S M Richards, 1995, Lancet.

Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).

M. Tallman, S. Richards, H. Lazarus, 2001 .

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay

S. Richards, A. G. Bosanquet, S. Johnson, 1999, British journal of haematology.

The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial.

D. Catovsky, R. Wade, C. Dearden, 2007 .

The Lack of Survival Differences in Randomised Trials in CLL May Be Related to the Effect of Second Line Therapies. A Report from the LRF CLL4 Trial.

D. Catovsky, S. Richards, P. Hillmen, 2006 .

Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.

M. Tallman, S. Richards, H. Lazarus, 2007 .

The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.

F. Speizer, R. Peto, S. Richards, 1983, The American review of respiratory disease.

Incidence of Hemolytic Anemia after Chemotherapy in the CLL4 Trial. A Possible Protective Role for Fludarabine Plus Cyclophosphamide.

D. Catovsky, S. Richards, 2004 .

Prognostic Factors in the UK LRF CLL4 Trial.

D. Catovsky, R. Wade, D. Oscier, 2005 .

Drug cross‐resistance and therapy‐induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing

M. Dyer, D. Catovsky, R. Wade, 2009, British journal of haematology.

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial

M. Tallman, S. Richards, A. Moorman, 2010 .

responders : a study of complete cytogenetic α Chronic myeloid leukemia and interferon-

J. Hasford, M. Baccarani, G. Rosti, 2013 .

Comparison of Oral and Intravenous Fludarabine in the LRF CLL4 Trial.

D. Catovsky, S. Richards, P. Hillmen, 2005 .

S. Richards, A. Vora, O. Eden, 2002 .

Final results of a randomized trial comparing autotransplant versus wait and watch in 222 patients with CLL in 1(st) or 2(nd) remission (EBMT CLL auto trial / GCLLSG CLL3R trial)

R. Brand, M. Hallek, S. Stilgenbauer, 2010 .

Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia – an individual patient data meta‐analysis involving 5659 children

R. Pieters, S. Richards, T. Eden, 2010, British journal of haematology.

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial

D C Linch, M R Mansour, R E Gale, 2013, Leukemia.

Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial

R. Houlston, D. Rossi, G. Gaidano, 2011, Haematologica.

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

M. Tallman, S. Richards, G. Dewald, 2008 .

Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).

D. Neuberg, M. Tallman, S. Richards, 1999 .

Medical Research Council Childhood Leukaemia Trial VIII compared with trials II-VII: lessons for future management.

J. Peto, S. Richards, O. Eden, 1987, Haematology and blood transfusion.

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups

M. Tallman, S. Richards, G. Dewald, 2010 .

Therapeutic interventions for endemic Burkitt's lymphoma in children

S. Richards, M. Meremikwu, J. Okebe, 2005 .

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

C. Mullighan, C. Willman, M. Tallman, 2020, British journal of haematology.

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003

R. Wade, S. Richards, A. Vora, 2008 .

Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durable complete remissions (CR). Results from the international ALL trial (MRC UKALL-XII/ECOG E2993)

M. Tallman, S. Richards, R. Chopra, 2004 .

The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study

M. Tallman, S. Richards, R. Chopra, 2004 .

Bone Marrow Transplantation Versus Chemotherapy in Acute Lymphoblastic Leukemia. Joint Trial of the Medical Research Council (UKALL-12) with the United States Eastern Cooperative Oncology Group E2993

S. Richards, H. Lazarus, J. Rowe, 1997 .

Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.

S. Richards, A. Leiper, J. Chessells, 1987, Archives of disease in childhood.

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.

S. Richards, G. Harrison, S. Kinsey, 2002 .

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study

Richards, S. Richards, O. Eden, 2000, British journal of haematology.

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

M. Tallman, S. Richards, R. Chopra, 2006, Blood.

L. Staudt, D. Weisenburger, J. Vose, 2007 .

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999

S. Richards, A. Vora, J. Chessells, 2002, British journal of haematology.

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome

S. Richards, C. Harrison, A. Moorman, 2003, Leukemia.

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL

A. Ferrando, M. Tallman, S. Richards, 2009 .

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003

R. Wade, S. Richards, A. Vora, 2008 .

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

R. Brand, M. Hallek, A. Gratwohl, 2009 .

importance . leukaemia and its clinical childhood lymphoblastic morphological classification of French American British ( FAB )

S. Richards, J. Lilleyman, R. Stevens, 2004 .

Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens: Results of the Medical Research Council Trial UKALL2003.

S. Richards, J. Hancock, A. Vora, 2008 .

MEDICAL RESEARCH COUNCIL TRIAL OF ANTILYMPHOCYTE GLOBULIN IN RENAL TRANSPLANTATION: A MULTICENTER RANDOMIZED DOUBLE‐BLIND PLACEBO CONTROLLED CLINICAL INVESTIGATION

R. Peto, R. Blamey, S. Richards, 1983, Transplantation.

The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-alpha (IFN alpha). A collaborative European study of 317 cases.

M. Baccarani, G. Martinelli, S. Richards, 2001 .

A randomised comparison of low or high dose IFN-alpha in newly diagnosed CML patients shows no difference in major cytogenetic response rate or survival between the two groups - Results of MRC CML V & HOVON 20 trials.

S. Cessie, H. Kluin-Nelemans, S. Richards, 2001 .